Dysregulation of Gene Expression in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Mouse Substantia Nigra

Parkinson's disease pathogenesis proceeds through several phases, culminating in the loss of dopaminergic neurons of the substantia nigra (SN). Although the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of oxidative SN injury is frequently used to study degeneration of dopaminergic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurosci
Main Authors: Miller, Renee M., Callahan, Linda M., Casaceli, Cindy, Chen, Linlin, Kiser, Gretchen L., Chui, Buena, Kaysser-Kranich, Tamma M., Sendera, Timothy J., Palaniappan, Chockalingam, Federoff, Howard J.
Formato: Artigo
Idioma:Inglês
Publicado em: Society for Neuroscience 2004
Assuntos:
Neurobiology of Disease
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6729635/
https://ncbi.nlm.nih.gov/pubmed/15329391
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.4204-03.2004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados